Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investor looking at stock graph on a tablet with their finger hovering over the Buy button
    Investing For Beginners

    Something big just happened in the UK stock market

    | Jon Smith

    Jon Smith talks through some data he's just found, which could indicate a positive change of sentiment for the UK…

    Read more »

    A senior group of friends enjoying rowing on the River Derwent
    Investing Articles

    5 simple steps for targeting a £1,000,000 SIPP

    | Zaven Boyrazian, MSc

    Through regular contributions and careful monitoring, investors can target a seven-figure long-term SIPP to improve their retirement quality of life.

    Read more »

    Person holding magnifying glass over important document, reading the small print
    Investing Articles

    Down 20% in 14 weeks, is AstraZeneca’s share price now too big a bargain for me to miss?

    | Simon Watkins

    AstraZeneca’s share price has fallen a long way on an investigation surrounding its Chinese business. So, do the shares look…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    Where might the AstraZeneca share price go in 2025? Here’s what the experts forecast

    | Zaven Boyrazian, MSc

    The AstraZeneca share price is down almost 20% since September! What’s behind this drop, and where do analysts think the…

    Read more »

    Growth Shares

    Directors at this FTSE 100 company just bought over £2m worth of shares

    | Edward Sheldon, CFA

    Shares in this FTSE 100 pharma company have plummeted in recent months. And company insiders are betting on a potential…

    Read more »

    Investing Articles

    2 top shares I’ve bought for my Stocks and Shares ISA in November

    | Ben McPoland

    This writer reveals a pair of fast-growing businesses that he's recently added to his Stocks and Shares ISA for the…

    Read more »

    Investing Articles

    What on earth is going on with the AstraZeneca share price?

    | Dr. James Fox

    The AstraZeneca share price has fallen 30% from its peak in August. Dr James Fox explains what’s going on with…

    Read more »

    Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
    Growth Shares

    The AstraZeneca share price just fell 8.4% in a day. Is it time to consider buying?

    | Edward Sheldon, CFA

    The AstraZeneca share price has fallen almost 25% since late August. Is there value on offer for investors after this…

    Read more »

    Investing Articles

    If I’d put £25,000 into the FTSE 350 at the start of 2024, here’s how much I’d have today!

    | Ben McPoland

    Many FTSE shares have rebounded this year as interest rates look set to keep heading lower and market appetite for…

    Read more »

    Investing Articles

    If I’d put £10,000 into the FTSE 100’s biggest stock at the start of 2024, here’s what I’d have now

    | Roland Head

    The FTSE 100’s biggest company has romped away from the index over the last five years, but has fallen behind…

    Read more »

    Arrow symbol glowing amid black arrow symbols on black background.
    Investing Articles

    As AstraZeneca’s share price drops 11%, does the stock look an unmissable bargain to me?

    | Simon Watkins

    AstraZeneca’s share price has fallen 11%, leaving it looking even more of a bargain to me than before, supported by…

    Read more »

    Dividend Shares

    Here are the 2025 dividend forecasts for FTSE giants Unilever, GSK, and AstraZeneca

    | Edward Sheldon, CFA

    These FTSE shares don’t have the highest yields. But Edward Sheldon believes they could deliver attractive returns in the years…

    Read more »